The Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 Inhibits Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption via Inhibition of TNF-α Expression in Macrophages

Glucagon-like peptide-1 (GLP-1) receptor agonists are an effective treatment approach for type 2 diabetes. Recently, anti-inflammatory effects of GLP-1 receptor agonists have also been reported. Lipopolysaccharide (LPS) induces inflammation and osteoclast formation. In this study, we investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Wei-Ren, Kimura, Keisuke, Ishida, Masahiko, Sugisawa, Haruki, Kishikawa, Akiko, Shima, Kazuhiro, Ogawa, Saika, Qi, Jiawei, Kitaura, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872659/
https://www.ncbi.nlm.nih.gov/pubmed/29725604
http://dx.doi.org/10.1155/2018/5783639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872659/
https://www.ncbi.nlm.nih.gov/pubmed/29725604
http://dx.doi.org/10.1155/2018/5783639

Ejemplares similares